Request a Trial
Hoodin is specifically designed to perform monitoring for a life science product throughout their entire life cycle. With Hoodin, you have the flexibility to set up monitoring for a specific product (brand name) or a product type (such as a device, IVD product, or drug.) The trial project you will have access to will be customized to monitor the product or product type of your preference.
You will get access to a 14- day free trial of Hoodin
Request a Trial
Hoodin is specifically designed to perform monitoring for a life science product throughout their entire life cycle. With Hoodin, you have the flexibility to set up monitoring for a specific product (brand name) or a product type (such as a device, IVD product, or drug.) The trial project you will have access to will be customized to monitor the product or product type of your preference.
You will get access to a 14- day free trial of Hoodin
Request a Trial
Hoodin is specifically designed to perform monitoring for a life science product throughout their entire life cycle. With Hoodin, you have the flexibility to set up monitoring for a specific product (brand name) or a product type (such as a device, IVD product, or drug.) The trial project you will have access to will be customized to monitor the product or product type of your preference.
You will get access to a 14- day free trial of Hoodin
Keep track of Quality and Standards
with Hoodin
This use case addresses the need to stay well informed about changes in standards and the latest insights and trends in how to keep quality operations at the top.
Building blocks for Quality and standards
Hoodin makes it easy for you. The expert-designed template for Quality and standards Intelligence comes with a number of building blocks called monitoring feeds. You may choose to use only a few of them or all. Every feed comes with recommended sources to monitor.
Monitor
Some of the available sources for Health Authorities
Standards organisations
Monitor global and local standards organisations for updates in standards and news from these organisations.
Some of the available sources
Monitor
Some of the available sources for Regulatory Trends & Insights
Quality management and technology
Monitor organisations, thought leaders and experts to retrieve the latest trends and insights regarding quality management and technology.
Monitor
Some of the available sources for Technology Trends & Insights
Quality Management Systems
Monitor organisations, thought leaders and experts to retrieve the latest trends and insights regarding Quality Management Systems (QMS) for Medtech and Pharma.
Monitor
Create custom Monitoring Feed
When selecting this option, you will be able to pick any of the sources available and build your own set of curated sources you wish to monitor.
Automation for efficiency
Through Hoodin, you may monitor specific sources and digital services for externally published content. You may also monitor a vast number of databases for literature as well as retrieve signals and fetch content when clinical trial data and adverse events regarding adjacent and or competitive devices and treatments are published.
Save time from manual,
repeated searches.
Don’t ever miss important updates in standards.
Easy collaboration with colleagues.
Create your own knowledge hub with relevant content.
Some of our customers & partners
By using Hoodin, our customers and partners are saving up to 90% time from manual, repeated searches. Learn more from our client cases and interviews below.
Partnership
"I can certainly see how this will save me time in my projects from a purely regulatory intelligence point of view, and I am also trialing the platform for a very specific project, which will be of benefit to both me and my clients. This speaks to the versatility of Hoodin’s platform."
Vince Wek, Bluefinch Medical
Regulatory Intelligence
Pharma
"With more than 20 years of experience in regulatory affairs, mainly from Pharma, I can say with great certainty that Hoodin's monitoring platform will facilitate a large part of the manual work that is linked to post market surveillance within medtech, as well as pharma's equivalent pharmacovigilance."
Nicholas Wells, CEO, Regulatory Index